Clinical Trial Update: Lenvatinib and Pembrolizumab in People With Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in adults with advanced soft tissue sarcoma; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Advanced Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING